ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      AI Subscribe Login/Register Profile Icon
      S&P 500
      5,830.84
      -0.09%
      US Tech 100
      20,249.20
      0.13%
      Dow Jones
      42,357.39
      0.14%
      Brent Oil
      79.66
      -0.77%
      Bitcoin
      95,776.21
      1.34%
      Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. Brazil
      5. BOV

      6. Bny Mellon DRN (BONY34) Quote

      Bny Mellon DRN

      Bny Mellon DRN (BONY34)

      BOV
      461.77
      -0.53
      ( -0.11% )
      Updated: 10:52:16
      Delayed by 15 minutes

      Professional-Grade Tools, for Individual Investors.

      Premium

      Key stats and details

      Current Price
      461.77
      Bid
      461.08
      Ask
      463.41
      Volume
      31
      461.77 Day's Range 463.26
      264.62 52 Week Range 512.00
      Market Cap
      355.135B
      Previous Close
      462.30
      Open
      463.26
      Last Trade
      1
      @
      461.77
      Last Trade Time
      10:39:32
      Financial Volume
      R$ 14,360
      VWAP
      463.212
      Average Volume (3m)
      116
      Shares Outstanding
      769,073,000
      Dividend Yield
      2.29%
      PE Ratio
      19.21
      Earnings Per Share (EPS)
      3.97
      Revenue
      16.71B
      Net Profit
      3.05B

      About Bny Mellon DRN

      Sector
      State Commercial Banks
      Industry
      National Commercial Banks - Non Islamic
      Website
      www.bnymellon.com
      Headquarters
      New York, New York, USA
      Founded
      2007
      Bny Mellon DRN is listed in the State Commercial Banks sector of the Brazil Bovespa Exchange with ticker BONY34. The last closing price for Bny Mellon DRN was R$462.30. Over the last year, Bny Mellon DRN shares have traded in a share price range of R$ 264.62 to R$ 512.00.

      Bny Mellon DRN currently has 769,073,000 shares outstanding. The market capitalization of Bny Mellon DRN is R$355.54 billion. Bny Mellon DRN has a price to earnings ratio (PE ratio) of 19.21.

      Ask ADVFN Intelligence (AI)

      BONY34 Latest News

      More News
      No news to show yet.
      PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
      1-3.78-0.81194286328465.55512459.5932473.40929688DR
      4-20.88-4.3261162333482.65512450.7329475.9322069DR
      1217.373.90864086409444.4512430116454.20689748DR
      26106.8730.112707805354.9512340.2582426.17505897DR
      52197.1574.5030609931264.62512264.62155325.57451023DR
      156111.3131.7611139645350.46512194.4282249.64701499DR
      260248.46116.478364821213.31512143.65306248.35186891DR

      BONY34 - Frequently Asked Questions (FAQ)

      What is the current Bny Mellon DRN share price?
      The current share price of Bny Mellon DRN is R$ 461.77
      How many Bny Mellon DRN shares are in issue?
      Bny Mellon DRN has 769,073,000 shares in issue
      What is the market cap of Bny Mellon DRN?
      The market capitalisation of Bny Mellon DRN is BRL 355.54B
      What is the 1 year trading range for Bny Mellon DRN share price?
      Bny Mellon DRN has traded in the range of R$ 264.62 to R$ 512.00 during the past year
      What is the PE ratio of Bny Mellon DRN?
      The price to earnings ratio of Bny Mellon DRN is 19.21
      What is the cash to sales ratio of Bny Mellon DRN?
      The cash to sales ratio of Bny Mellon DRN is 3.51
      What is the reporting currency for Bny Mellon DRN?
      Bny Mellon DRN reports financial results in USD
      What is the latest annual turnover for Bny Mellon DRN?
      The latest annual turnover of Bny Mellon DRN is USD 16.71B
      What is the latest annual profit for Bny Mellon DRN?
      The latest annual profit of Bny Mellon DRN is USD 3.05B
      What is the registered address of Bny Mellon DRN?
      The registered address for Bny Mellon DRN is 225 LIBERTY STREET, NEW YORK, NEW YORK, 10286
      What is the Bny Mellon DRN website address?
      The website address for Bny Mellon DRN is www.bnymellon.com
      Which industry sector does Bny Mellon DRN operate in?
      Bny Mellon DRN operates in the NATIONAL COMMERCIAL BANKS - NON ISLAMIC sector

      Movers

      View all
      • Most Active
      • % Gainers
      • % Losers
      SymbolPriceVol.
      FICT3Fictor Alimentos S.A.
      R$ 3.14
      (7.53%)
      		27k
      TEKA4Teka Tecelagem Kuehnrich Sa
      R$ 34.00
      (7.42%)
      		100
      HBRE3HBR Realty Empreendimentos Imobiliarios SA
      R$ 3.00
      (6.01%)
      		508.8k
      DOTZ3Dotz S.A.
      R$ 3.28
      (5.47%)
      		3.2k
      INEP4Inepar Sa Ind Construcoes
      R$ 1.36
      (5.43%)
      		33.7k
      AMAR11Lojas Marisa S.A.
      R$ 0.58
      (-6.45%)
      		3.5k
      WHRL3Whirlpool Sa
      R$ 3.76
      (-4.57%)
      		1,000
      RNEW4Renova Energia SA
      R$ 0.90
      (-3.23%)
      		35.9k
      LUPA3Lupatech SA
      R$ 1.25
      (-3.10%)
      		25.3k
      AMOB3Automob Participacoes Sa
      R$ 0.33
      (-2.94%)
      		4.75M
      CPLE3Cia Paranaense Energia Copel
      R$ 7.96
      (0.51%)
      		23.83M
      HAPV3Hapvida Participacoes Investimento SA
      R$ 2.15
      (-0.46%)
      		18.63M
      BBDC4Bco Bradesco Sa
      R$ 11.24
      (0.178253%)
      		14.87M
      ASAI3Sendas Distribuidora S.A.
      R$ 5.40
      (-2.17%)
      		14.82M
      COGN3CognaEducacao SA
      R$ 1.14
      (0.00%)
      		13.27M

      Discussion

      View Full Feed
      canthelpit canthelpit 4 minutes ago
      Pretty sad a 1 mil sell drops us to trip 1 but a 25 mil dump drops us to 00015 i saw the other day ,,, They in control of this need to let it run ,, Would be benificial to all !!! IT;S COMING !!!!!!!!!!!!!!!!!!! GLTA
      GTCH
      devil dog 96 devil dog 96 4 minutes ago
      I got the same notice from Schwab today for the same offer. Who would sell at $7.50 right now? 😃

      " yes, through Schwab. Rumble wants to buy your shares at $7.50 per share ."

      Unless they can get her to tank below $7.50 before the dead line date of the offer I do
      RUM RUMBW
      green maschine green maschine 4 minutes ago
      Well the day is still early, let's hope for a higher close than this.
      TNXP
      ShawnP123 ShawnP123 4 minutes ago
      Being surprised yesterday regarding not being down as much. It's making up for that today. Wouldn't surprise me to see the next barrier to cross being 130.
      NVDA
      georgejjl georgejjl 4 minutes ago
      That is WRONG!!!

      No one has posted an obituary for either Ern Heaven or his wife.

      GOD bless,
      AVXL
      PennyStockTrader2 PennyStockTrader2 4 minutes ago
      if they are taking a loss and need the money, which all the private placement folks would be in that situation, then yes its very possible.
      IPSI
      getmoreshares getmoreshares 4 minutes ago
      added on the dip
      BHAT
      gdl gdl 4 minutes ago
      WHY is the market NOT recovering? PPI was flat. Inflation seems tame. I guess it is the convicted felons plan that has them on edge. But wait, they now say Tariffs will be S-l-o-w-l-y implemented. Drip by drip so inflation would never happen. Got it. This as Trump and some Senators are actuall
      Rambo Rell Rambo Rell 5 minutes ago
      $ILLR: Bridging Digital and Physical
      From online engagement to live events, Triller connects the dots in ways no other platform can. Invest in connectivity. #DigitalMeetsRealWorld #ILLR
      ILLR
      DewDiligence DewDiligence 5 minutes ago
      It's not just what Brian Lian said, but also what Big Pharma CEOs are saying. For instance, PFE's CEO Albert Bourla said on yesterday's JPM webcast that it's "a little late" to be developing an injected GLP-1-based therapy. PFE wants oral molecules and/or non-GLP-1 mechanisms. (There was no update o
      GLP JPM PFE
      Rambo Rell Rambo Rell 5 minutes ago
      $ILLR: Bridging Digital and Physical
      From online engagement to live events, Triller connects the dots in ways no other platform can. Invest in connectivity. #DigitalMeetsRealWorld #ILLR
      ILLR
      ArchieK ArchieK 5 minutes ago
      You didn't seem a Lululemon kinda guy. ;)
      CDMO
      Doubledown75 Doubledown75 5 minutes ago
      I like this one 
      ARMN
      Edward Edward 5 minutes ago
      Sure they don’t!

      So what does this quote mean as to VXIT?

      That’s right guys please help drop the price! I have orders in! Keep the bashing up!!! Love it! Get more people scared!
      VXIT
      Rambo Rell Rambo Rell 5 minutes ago
      $ILLR: User Growth on the Rise
      Triller is gaining traction globally, with millions joining our vibrant community. Early investors see the biggest rewards. #ILLR #GrowthOpportunity
      ILLR
      Rambo Rell Rambo Rell 5 minutes ago
      $ILLR: User Growth on the Rise
      Triller is gaining traction globally, with millions joining our vibrant community. Early investors see the biggest rewards. #ILLR #GrowthOpportunity
      ILLR
      SCAMBUSTERKING SCAMBUSTERKING 5 minutes ago
      I still see no lawsuit in NY courts to get the records from the TA. Filings needed to get current require shareholder equity to be calculated, which requires assessment of changes in share structure year over year. So filings cannot be submitted until that is received, which seems to not even be sta
      BCAP
      Avx4L Avx4L 5 minutes ago
      Exactly, any ideas on why they haven't PR'd this final version of the peer reviewed article? This is a huge accomplishment for Anavex.
      AVXL
      krab krab 5 minutes ago
      Today, looks like FNMA wants to touch $7 !!
      FNMA $6.94 Vol 21M
      FNMA
      wxdog wxdog 5 minutes ago
      Share Structure Updated this morning.

      Unchanged. Further, hasn’t changed for going on a year and a half.

      Ceramedx and all the skin care products are everywhere now. Great reviews too boot! 😀

      ~ $8 million market cap - undervalued bigly. 2/3rds of
      XCRT
      12x 12x 6 minutes ago
      I found it puzzling that yesterday's PR did not include a standard summary chart, like the one provided by Leqembi, to consolidate key metrics (N, score, trend, etc.) into a single graph. This is especially notable given the headline claim, 'Topline ATTENTION-AD trial: Patients showed improved cogni
      AVXL
      3antar 3antar 6 minutes ago
      Could we see an executive order for release on day one! Is this even an option!
      FNMA
      jcromeenes jcromeenes 6 minutes ago
      It's about releasing the GSEs. His plans.
      FNMA
      linkvest linkvest 6 minutes ago
      Thinking the same thing Thunder. MMs are doing their best to keep it in their channel.
      RDAR
      AverageJoe AverageJoe 6 minutes ago
      LegalFi? Quick Goog reveals NOTHING LMAO
      BCDS

      Your Recent History

      BOV
      BONY34
      Bny Mellon DRN
      Delayed Upgrade Clock

      Go Ad-Free

      Subscribe to Ad free and enjoy an ad-free experience

      No Ads

      Try Now

      Keep the Ads